David Sidransky

David Sidransky

Patrimonio netto: 5 M $ in data 30/06/2026

66 anni
Health Technology
Health Services
Consumer Services

Profilo

David Sidransky founded Israel Biotech Fund in 2014, where he is working as General partner from 2014 and Champions Oncology, Inc. in 1985, where he is working as Independent Director from 2025.
Dr. Sidransky also currently works at Biosight Therapeutics, Inc., as Chairman from 2013, Advaxis Immunotherapies, as Chairman, Ayala Pharmaceuticals, Inc., as Chairman from 2017, and various other companies.
Dr. Sidransky also formerly worked at Tamir Biotechnology, Inc., as Chairman from 2007 to 2020, ImClone LLC, as Vice Chairman from 2004 to 2008, Old Ayala, Inc., as Chairman from 2017 to 2023, and various other companies.
Dr. Sidransky received his undergraduate degree in 1981 from Brandeis University and doctorate degree from Baylor College of Medicine.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
05/11/2025 767.043 ( 5,52% ) 5 M $ 30/06/2026
20/04/2026 18.491 ( 0% ) 78 283 $ 30/06/2026
25/03/2026 11.083 ( 0,17% ) 6 162 $ 30/06/2026

Posizioni attive di David Sidransky

SocietàPosizioneInizio
CHAMPIONS ONCOLOGY, INC. Fondatore 04/06/1985
GALMED PHARMACEUTICALS LTD. Direttore/Membro del Consiglio 01/06/2014
IMMUNE PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 26/08/2013
ROSETTA GENOMICS LTD. Direttore/Membro del Consiglio 22/12/2009
ASCENTAGE PHARMA GROUP INTERNATIONAL Direttore/Membro del Consiglio 31/03/2021
AYALA PHARMACEUTICALS, INC. Presidente 01/11/2017
Corporate Officer/Principal 01/01/1994
Corporate Officer/Principal 01/07/1998
Direttore/Membro del Consiglio -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Precedenti posizioni note di David Sidransky

SocietàPosizioneFine
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░ ░░░░░ ░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di David Sidransky

Formazione di David Sidransky

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

58

Relazioni di 1° grado

35

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private35

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Services

Health Technology

Clinical Cancer Research

Commercial Services

Health Services

Health Services

Government

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

The American Association of Cancer Research

Health Services

Health Technology

  1. Mercati
  2. Insiders
  3. David Sidransky